show episodes
 
Artwork
 
BioTalk is a pro-life video series about all things bioethics, especially those issues related to human biotechnology — cloning, embryonic stem cell research, genetic engineering, transhumanism, etc…
  continue reading
 
Loading …
show series
 
Dr. Tim Richardson from Wichita Urology and Dr. Jonathan Henderson from Arkansas Urology discuss the use and benefits of Prolaris testing in prostate cancer management. Dr. Henderson elaborates on how Prolaris aids in decision-making for his prostate cancer patients, highlighting its role in reducing overtreatment and undertreatment.…
  continue reading
 
Dr. Tim Richardson from Wichita Urology interviews Dr. Scott Sellinger, the current president - elect of the Large Urology Group Practice Association (LUGPA). They discuss LUGPA's history, current status, and future goals. Initially founded to support large independent urology practices, LUGPA now includes any independent urology practice. Dr. Sell…
  continue reading
 
In this episode of The Modern Urologist, Dr. Mark Edney is joined by Dr. Paul Sieber, a urologist from Lancaster, Pennsylvania, to discuss the use of genetic testing in the diagnosis and treatment of prostate cancer. Dr. Sieber emphasizes the importance of hereditary cancer testing, as well as tissue-based biomarkers like Prolaris®, in determining …
  continue reading
 
On this episode of TMU we're diving deep into the rapidly evolving landscape of prostate cancer diagnosis and treatment with special guest, Dr. Adam Cole, a board-certified pathologist. Dr. Cole will discuss the traditional Gleason grading system, the limitations of pathology, and how incorporating genetic markers can improve patient outcomes. Dr. …
  continue reading
 
In this episode of TMU we have the pleasure of being joined by two urology experts, Dr. Ravi Rajan, Urologist, and Dr. William Ding, Radiation Oncologist, as they discuss topics ranging from genetic testing in prostate cancer for personalized treatment plans to the importance of collaboration between urologists and radiation oncologists. Our guests…
  continue reading
 
Join our panel of experts, Dr. Neal Shore, Dr. Ben Lowentritt, Dr. Ted Schaefer, and Dr. Jonathan Tward, as they discuss the various components and utility of a full workup for localized prostate cancer. They explore the importance of germline testing and how it has significant implications for personalized treatment choices. They will also discuss…
  continue reading
 
On this episode of TMU, Dr. Mark Edney welcomes Dr. Deepak Kapoor as they dive into the world of private equity and healthcare policy. They discuss the opportunities and challenges faced by private practices in the field of Urology, and explore the topic of private equity with Dr. Kapoor's experiences as the chairman of Solaris Health. Listeners wi…
  continue reading
 
On this episode of TMU, we sit down with Ray Wezik, the Director of Policy and Advocacy for the American Urological Association (AUA), as we dive into the world of patient advocacy and lobbying. Ray shares his perspective as someone who works with over 75 patient advocacy organizations to leverage their voices and become better advocates together. …
  continue reading
 
On this episode of TMU, we’re joined by Nilay Gandhi, Urologist at Potomac Urology in Northern Virginia, as he shares his personal story on why he chose to pursue urology and his involvement in patient advocacy. Dr. Gandhi also discusses how incorporating genetic testing into his practice has improved patient care. Lastly, we’ll cover the growing p…
  continue reading
 
Dr. TJ Slavin, Chief Medical Officer of Myriad Genetics hosts this episode of the Modern Urologist joined by Dr. Angelo Baccala, at Lehigh Valley Health Network and Kara Cossis, PA-C, MPH, at Chesapeake Urology, to discuss genetic testing advancements in prostate cancer care to improve patient outcomes. Panelists' will dive into the rising rates of…
  continue reading
 
In this episode of The Modern Urologist, we are joined by Dr. David Levy who has done extensive research on prostate cancer nutrition and treatment. Dr. Levy will discuss measures that can be taken to decrease risk of disease such as taking supplements and vitamins. In addition, he mentions which foods to incorporate in your diet and those to avoid…
  continue reading
 
In the first of a two-part series, Shelby Moneer, VP of Patient Programs and Education and Ali Manson, VP of Government Relations at ZERO – The End of Prostate Cancer, join Dr. Todd Cohen to discuss their advocacy efforts to educate and support all men who are impacted by prostate cancer. They will discuss ZERO's health equity work to combat racial…
  continue reading
 
In this episode Dr. Todd Cohen is joined by Geoff McLennan, a board member of Active Surveillance Patients International (ASPI), an advocacy group created by men with prostate cancer for men with prostate cancer. When Geoff was diagnosed with localized prostate cancer he was shocked to hear he could actively watch his cancer and not undergo extensi…
  continue reading
 
In this episode, two guests from Urology Austin, Jessica Stewart, VP of Business Development, and Marco Carlos, Clinical Care Director, join Dr. Cohen to discuss their elevated nurse navigation program and how they care for their prostate cancer patients. They will talk through the implementation of clinical care pathways across the entire prostate…
  continue reading
 
Dr. Marc Greenstein, from Advanced Urology, joins Dr. Todd Cohen to discuss his various roles as a urologist in the community and how he decided to get into the field of Urology. Dr. Greenstein provides insight to how his practice has adapted to the COVID-19 pandemic and dives into where he sees the future of Urology going.…
  continue reading
 
In this episode, Radiation Oncologist, Jeffery Skinner from Chesapeake Urology sits down with Dr. Todd Cohen to discuss how a radiation oncologist determines the proper treatment for a prostate cancer patient. Dr. Skinner will also share his thoughts on androgen deprivation therapy (ADT) in conjunction with radiation treatment.…
  continue reading
 
In this installment of The Modern Urologist, Dr. Todd Cohen was able to sit down with Neal Dunn, a former urologist and current Congressman of Florida’s 2nd Congressional District. They will discuss his transition from a practicing urologist to a politician, along with the biggest battles and successes he has faced in this role thus far. Congressma…
  continue reading
 
Dr. Howard Soule, Chief Scientific Officer of the Prostate Cancer Foundation, joins Dr. Todd Cohen on this episode of The Modern Urologist to discuss his involvement with the Prostate Cancer Foundation. He will also talk through the history of the foundation and where he sees them going in the future. In addition, Dr. Soule gives insight to how the…
  continue reading
 
In this episode, Dr. Laurence Klotz, Professor of Surgery at the University of Toronto, sits down with Dr. Todd Cohen to discuss his role in the advancement of Active Surveille in Urology. He dives into how himself and two colleagues came up with a strategy to reduce over treatment in prostate cancer patients. Dr. Klotz will also talk about the ear…
  continue reading
 
In this episode, Dr. Todd Cohen sits down with cancer survivor John Earp to talk about his journey from diagnosis to treatment and life beyond. John was diagnosed with cancer at age 46 also shares his extensive cancer history and how he eventually learned that his prostate cancer was caused by a hereditary mutation known as CHEK-2.…
  continue reading
 
In the first episode of a two-part series on focal therapies, Dr. Samuel Peretsman from Urology Specialists North Carolina joins Dr. Todd Cohen to talk about his early involvement using High intensity focused Ultrasound (HIFU). Dr. Peretsman discusses in-detail the unique path he took to became an expert with this technology and how he uses it in t…
  continue reading
 
In this episode, Pathologist, Dr. Adam Cole and Urologist Dr. Richard Bevan-Thomas join The Modern Urologist to discuss how improved collaboration and communication between the two specialty groups has lead to better patient risk stratification and treatment plans. Multiple patient case reviews are discussed in-detail and the use of personalized ma…
  continue reading
 
Alan Winkler, Executive Director of Urology San Antonio shares his experience with bringing a new EHR system online. The technical challenges of building out existing clinical pathways and the steps taken internally to get the requisite physician and staff adoption are discussed in-detail. The additional value behind upgrading to a new EHR and how …
  continue reading
 
In this episode, Dr. Todd Cohen kicks off prostate cancer awareness month by interviewing prostate cancer survivor - Byron Sparkman. Byron shares his personal cancer journey starting at the time he learned of his elevated PSA, to getting a biopsy, and the additional steps he took to feel comfortable making a treatment decision. Byron also shares hi…
  continue reading
 
Dr. Paul Sieber continues his conversation with Dr. Todd Cohen around managing the advanced prostate cancer patient. The use of somatic and germline testing to support decision making within the treatment algorithm are discussed. Medical management changes of positive mutation carriers and the commercial use of PARP inhibitors are also explored.…
  continue reading
 
Dr. Walter Rayford joins Dr. Todd Cohen to talk about the racial disparities among African American men and prostate cancer. Dr. Rayford has been extensively involved in researching discrepancies in prostate cancer disease outcomes and shares his experiences and recommendations for better educating and treating the African American patient. Dr. Ray…
  continue reading
 
In this episode, Dr. Neal Shore, with Atlantic Urology Clinics in Myrtle Beach, South Carolina, and Medical Director at Carolina Urologic Research Center discusses how his practice continues to adapt to the current COVID-19 pandemic, specifically around the importance of patient prioritization during their recovery phase. Strategies to better decid…
  continue reading
 
Dr. Cohen continues his conversation with Urologists and CEOs Dr. Ed Cohen and Dr. David Ellis on how their respective practices continue to adapt to the current crisis. The topics of federal loan programs, personal protective equipment (PPE) and the processes behind successfully executing tele-health are discussed.…
  continue reading
 
In this episode of the COVID-19 series, Dr. David Ellis and Dr. Ed Cohen continue to share how they have further adapted their individual operations and practices to deal with the current pandemic. Both CEOs share at-length their short and long-term concerns and how they plan to manage patients once social distancing guidelines are rescinded.…
  continue reading
 
Wayne Sotile, PhD, founder of the Sotile Center for Resilience and the Center for Physician Resilience shares some powerful ideas on how physicians and other healthcare providers can manage individual burnout. Drawing on this extensive experience, Dr. Sotile shares how physicians can become more resilient, even thrive in times of increased stress.…
  continue reading
 
In this episode, Dr. Todd Cohen follows up on his previous conversation with Dr. David Ellis, and Dr. Ed Cohen on how these providers and their practices continue to adapt and evolve patient care amid the COVID-19 pandemic. The challenges associated with implementing tele-health workflows to maintain existing patient volume is discussed at length. …
  continue reading
 
Dr. Cohen sits down with Dr. David Ellis from MidLantic Urology and Dr. Edward Cohen, from Genesis Healthcare to talk about the challenges of managing their day-to-day operations amid the COVID-19 pandemic. The use of digital technology, like tele-medicine is being implemented to ensure that routine urological care continues while keeping patients …
  continue reading
 
In this episode, Dr. Matthew Cooperberg, Urologist and Professor of Urology; Epidemiology & Biostatistics at UCSF talks about the parallels between breast and prostate cancer and how precision medicine in Urology is continuously evolving. The role of family history, mutation status, and the impact it is having on current and future prostate cancer …
  continue reading
 
Dr. Brian Richardson, Urologist and men's health activist talks about his experience dealing with prostate cancer in his own family and how it influenced him to pursue a career in Urology. Dr. Richardson also shares his passion for men's health advocacy and how it led him to create the first fun run in Montgomery, Alabama geared towards education a…
  continue reading
 
In this episode, The Modern Urologist sits down with Dr. Angelo Baccala, Division Chief of Urology at Lehigh Valley Hospital Network to talk about his motivation for pursuing an MBA and the benefits it provides. The idea of protocols and pathways are discussed as a means to combat variation in patient care, while improving upon workflow efficiency.…
  continue reading
 
Dr. Mike Gambla from Central Ohio Urology Group joins The Modern Urologist to talk about his experience with private equity acquisitions (PE) in the Urology space. The idea of potential culture disruptions and other pros and cons of PE acquisitions are discussed at length. Dr. Gambla offers his own insights to any independent practice considering a…
  continue reading
 
In this episode, The Modern Urologist sits down with Dr. David Morris, from Urology Associates P.C. in Tennessee to talk about the history of MRI and the impact it can have on biopsy and surgical planning. Dr. Morris further discusses societal MRI guidelines, the utilization in mainstream urology and how he personally uses this technology in his tr…
  continue reading
 
In this episode, The Modern Urologist sits down with E.Scot Davis, CEO of Arkansas Urology to talk about his experience creating men's health clinics and advance pathways to improve the competitive advantage of his organization. The conversation then dives into Scot's vast experience managing large group physician practices and how he developed a u…
  continue reading
 
In this episode, The Modern Urologist sits down at LUGPA with Dr. Jason Haffron, from Michigan Institute of Urology to talk about how his patient first mentality inspired him to develop new treatment pathways. The topic of being a young practicing urologist and how to become an influence within a well-established group practice are discussed. Treat…
  continue reading
 
In this episode, Dr. Cohen sits down at AACU with Dr Benjamin Lowentritt, Director of the Prostate Cancer Care Program at Chesapeake Urology to talk about his experience setting up advanced prostate cancer clinics. Dr. Lowentritt also talks at length about the collaborative model he and his partners are using to develop processes for delivering new…
  continue reading
 
In this episode Dr. Cohen sits down with Dr. Jonathan Henderson, CEO of Regional Urology in Shreveport Louisiana to discuss how the Prolaris test changed his treatment decision of multiple patients considering treatment or active surveillance. Dr. Henderson also talks about his reasoning for the early adoption of hereditary cancer screening and sha…
  continue reading
 
In this episode, Dr. Cohen sits down with Sarah Nielsen, Genetic Counselor to talk about her experience educating and developing screening protocols for providers who are new to the genetics space. The implications of genetic mutations,family history and the limitations of access to genetic counselors are also discussed and how collaborative soluti…
  continue reading
 
In this episode, Dr. Cohen sits down with Dr. Mark Edney, Medical Director at Peninsula Institute for Laparoscopic and Robotic Surgery to discuss the limitations of relying on clinical pathology alone and how the addition of Prolaris allows providers to truly understand how a patient's tumor is behaving on a biological level. Dr, Edney also talks a…
  continue reading
 
The first GMO baby was born this year using the "3-parent IVF" method called “maternal spindle transfer”. If not for the Aderholt amendment to the 2015 omnibus spending bill, which prohibits the Food and Drug Administration from entertaining any submission that proposes “research in which a human embryo is intentionally created or modified to inclu…
  continue reading
 
Loading …

Quick Reference Guide